申请人:Happonen Pertti
公开号:US20050143361A1
公开(公告)日:2005-06-30
An inhalation medicament comprising orazipone and a beta2-adrenoreceptor agonist and/or a corticosteroid as a combined preparation. Optionally the medicament also comprises one or more pharmaceutically acceptable additive, diluents or carriers. The beta-2adrenoreceptor agonist and the corticosteroid may comprise, respectively, formoterol and budesonide.
一种吸入药剂,由奥拉西朋和β2-肾上腺素受体激动剂和/或皮质类固醇组合而成。药剂还可选择包含一种或多种药学上可接受的添加剂、稀释剂或载体。2-肾上腺素受体激动剂和皮质类固醇可分别包括福莫特罗和布地奈德。